UiPath faces a sell rating due to high competitive risks and limited upside versus larger AI peers. PATH demonstrates strong KPIs: $1.8B ARR, >100% net retention, and double-digit growth, but faces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results